Loading... Please wait... Loading... Please wait...
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | revenue | rating |
|---|---|---|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. | $2.31 | $157.41 M | -2.5 | 51 | $0 | ||
| Absci Corporation | $3.17 | $495.31 M | -3.78 | 155 | $5.72 M | ||
| Adverum Biotechnologies, Inc. | $6.85 | $152.56 M | -0.72 | 121 | $3.60 M | ||
| C4 Therapeutics, Inc. | $4.51 | $320.64 M | -1.97 | 145 | $20.76 M | ||
| Day One Biopharmaceuticals, Inc. | $13.71 | $1.12 B | -5.11 | 174 | $0 | ||
| Eledon Pharmaceuticals, Inc. | $2.45 | $107.05 M | -2.26 | 20 | $0 | ||
| Erasca, Inc. | $2.18 | $647.94 M | -2.83 | 126 | $0 | ||
| Edgewise Therapeutics, Inc. | $19.43 | $1.65 B | -11.47 | 92 | $0 | ||
| Generation Bio Co. | $2.17 | $216.88 M | -1.28 | 174 | $5.90 M | ||
| Galera Therapeutics, Inc. | $0.13 | $5.93 M | -0.12 | 7 | $0 | ||
| Icosavax, Inc. | $15.31 | $769.04 M | -6.96 | 60 | $582,000 | ||
| Inozyme Pharma, Inc. | $4.49 | $286.39 M | -3.43 | 59 | $0 | ||
| Kronos Bio, Inc. | $1.15 | $44.62 M | -0.37 | 61 | $6.29 M | ||
| Kezar Life Sciences, Inc. | $0.58 | $49.85 M | -0.49 | 58 | $7.00 M | ||
| Oncternal Therapeutics, Inc. | $7.10 | $24.27 M | -0.67 | 27 | $785,000 | ||
| Passage Bio, Inc. | $0.90 | $73.04 M | -0.77 | 58 | $0 | ||
| Phathom Pharmaceuticals, Inc. | $10.31 | $620.47 M | -2.38 | 452 | $682,000 | ||
| Replimune Group, Inc. | $8.09 | $485.18 M | -2.44 | 331 | $0 | ||
| Stoke Therapeutics, Inc. | $13.12 | $774.50 M | -6.14 | 110 | $8.78 M | ||
| 2seventy bio, Inc. | $4.02 | $201.25 M | -0.9 | 274 | $100.39 M | ||
| VectivBio Holding AG | $16.87 | $1.06 B | -8.03 | 0 | $27.34 M | ||
| X4 Pharmaceuticals, Inc. | $0.55 | $169.62 M | -1.51 | 116 | $0 |
